ArticleInternational journal of oncology2013

Galiximab (anti-CD80)-induced growth inhibition and prolongation of survival in vivo of B-NHL tumor xenografts and potentiation by the combination with fludarabine.

Kandasamy Hariharan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.